Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population

References

• Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet (London, England). 2008;371:1513–1518.
   PubMed Web of Science ®Google Scholar
• Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet (London, England). 2005;365:217–223.
   PubMed Web of Science ®Google Scholar
• Lewington S, Lacey B, Clarke R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. 2016;176:524–532.
   PubMed Web of Science ®Google Scholar
• Chandra A, Neeland IJ, Berry JD, et al. The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas heart study. J Am Coll Cardiol. 2014;64:997–1002.
   PubMed Web of Science ®Google Scholar
• Mikhail N, Tuck ML. Epidemiological and clinical aspects of obesity related hypertension. J Clin Hyper (Greenwich, Conn). 2000;2:41–45.
   PubMedGoogle Scholar
• DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Reviews Endocrinol. 2014;10:364–376.
   PubMed Web of Science ®Google Scholar
• van Gaal LF, Mertens IL, de Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–880.
   PubMed Web of Science ®Google Scholar
• Cornier MA, Despres JP, Davis N, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011;124:1996–2019.
   PubMed Web of Science ®Google Scholar
• Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34:791–799.
   PubMed Web of Science ®Google Scholar
• Gomez-Ambrosi J, Silva C, Galofre JC, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36:286–294.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (London, England). 2005;366:1640–1649.
   PubMed Web of Science ®Google Scholar
• Canoy D, Boekholdt SM, Wareham N, et al. Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007;116:2933–2943.
   PubMed Web of Science ®Google Scholar
• Seven E, Thuesen BH, Linneberg A, et al. Abdominal adiposity distribution quantified by ultrasound imaging and incident hypertension in a general population. Hypertension (Dallas, Tex : 1979). 2016;68:1115–1122.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. Jama. 2012;308:1150–1159.
   PubMed Web of Science ®Google Scholar
• Schneider HJ, Klotsche J, Silber S, et al. Measuring abdominal obesity: effects of height on distribution of cardiometabolic risk factors risk using waist circumference and waist-to-height ratio. Diabetes Care. 2011;34:e7.
   PubMedGoogle Scholar
• Zhang X, Shu XO, Li H, et al. Visceral adiposity and risk of coronary heart disease in relatively lean Chinese adults. Int J Cardiol. 2013;168:2141–2145.
   PubMed Web of Science ®Google Scholar
• Coutinho T, Goel K, Correa de Sa D, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. 2011;57:1877–1886.
   PubMed Web of Science ®Google Scholar
• Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124:e837–41.
   PubMed Web of Science ®Google Scholar
• Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–1049.
   PubMed Web of Science ®Google Scholar
• Zhang ZQ, Deng J, He LP, et al. Comparison of various anthropometric and body fat indices in identifying cardiometabolic disturbances in Chinese men and women. PloS One. 2013;8:e70893.
   PubMed Web of Science ®Google Scholar
• Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring, Md). 2011;19:1083–1089.
   PubMed Web of Science ®Google Scholar
• Melmer A, Lamina C, Tschoner A, et al. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors. Obesity (Silver Spring, Md). 2013;21:775–781.
   PubMed Web of Science ®Google Scholar
• Elisha B, Rabasa-Lhoret R, Messier V, et al. Relationship between the body adiposity index and cardiometabolic risk factors in obese postmenopausal women. Eur J Nutr. 2013;52:145–151.
   PubMed Web of Science ®Google Scholar
• Marcadenti A, Fuchs FD, Moreira LB, et al. Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference. Atherosclerosis. 2017;266:145–150.
   PubMed Web of Science ®Google Scholar
• D’Elia L, Manfredi M, Sabino P, et al. The Olivetti heart study: predictive value of a new adiposity index on risk of hypertension, blood pressure, and subclinical organ damage. Nutr Metab Cardiovasc Dis. 2016;26:630–636.
   PubMed Web of Science ®Google Scholar
• Johnson W, Chumlea WC, Czerwinski SA, et al. Concordance of the recently published body adiposity index with measured body fat percent in European-American adults. Obesity (Silver Spring, Md). 2012;20:900–903.
   PubMed Web of Science ®Google Scholar
• Lopez AA, Cespedes ML, Vicente T, et al. Body adiposity index utilization in a Spanish Mediterranean population: comparison with the body mass index. PloS One. 2012;7:e35281.
   PubMed Web of Science ®Google Scholar
• Wakabayashi I, Daimon T. The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274–278.
   PubMed Web of Science ®Google Scholar
• Wakabayashi I, Sotoda Y, Hirooka S, et al. Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease. Clin Chim Acta. 2015;446:231–236.
   PubMed Web of Science ®Google Scholar
• Wakabayashi I. A U-shaped relationship between alcohol consumption and cardiometabolic index in middle-aged men. Lipids Health Dis. 2016;15:50.
   PubMed Web of Science ®Google Scholar
• Ioachimescu AG, Brennan DM, Hoar BM, et al. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring, Md). 2010;18:1836–1844.
   PubMed Web of Science ®Google Scholar
• Nascimento-Ferreira MV, Rendo-Urteaga T, Vilanova-Campelo RC, et al. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults. Clin Nutr. 2017;36:1693–1700.
   PubMed Web of Science ®Google Scholar
• Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis. 2010;9:45.
   PubMed Web of Science ®Google Scholar
• Li Z, Bai Y, Guo X, et al. Alcohol consumption and cardiovascular diseases in rural China. Int J Cardiol. 2016;215:257–262.
   PubMed Web of Science ®Google Scholar
• Zhang N, Chen S, Chen Y, et al. Daytime sleepiness is associated with hyperhomocysteinemia in rural area of China: a cross-sectional study. Eur J Intern Med. 2016;35:73–77.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254:555–563.
   PubMed Web of Science ®Google Scholar
• Deng WW, Wang J, Liu MM, et al. Body mass index compared with abdominal obesity indicators in relation to prehypertension and hypertension in adults: the CHPSNE study. Am J Hypertens. 2013;26:58–67.
   PubMed Web of Science ®Google Scholar
• Nyamdorj R, Qiao Q, Soderberg S, et al. Comparison of body mass index with waist circumference, waist-to-hip ratio, and waist-to-stature ratio as a predictor of hypertension incidence in Mauritius. J Hypertens. 2008;26:866–870.
   PubMed Web of Science ®Google Scholar
• Sakurai M, Miura K, Takamura T, et al. Gender differences in the association between anthropometric indices of obesity and blood pressure in Japanese. Hypertens Res. 2006;29:75–80.
   PubMed Web of Science ®Google Scholar
• Chen X, Du H, Zhang J, et al. Adiposity and blood pressure among 55 000 relatively lean rural adults in southwest of China. J Hum Hypertens. 2015;29:522–529.
   PubMed Web of Science ®Google Scholar
• Lee CM, Huxley RR, Wildman RP, et al. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008;61:646–653.
   PubMed Web of Science ®Google Scholar
• Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev. 2002;3:141–146.
   PubMedGoogle Scholar
• Nazare JA, Smith JD, Borel AL, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am J Clin Nutr. 2012;96:714–726.
   PubMed Web of Science ®Google Scholar
• Barreira TV, Staiano AE, Harrington DM, et al. Anthropometric correlates of total body fat, abdominal adiposity, and cardiovascular disease risk factors in a biracial sample of men and women. Mayo Clinic Proceedings. 2012;87:452–460.
   PubMed Web of Science ®Google Scholar
• de Oliveira CM, Ulbrich AZ, Neves FS, et al. Association between anthropometric indicators of adiposity and hypertension in a Brazilian population: Baependi heart study. PloS One. 2017;12:e0185225.
   PubMed Web of Science ®Google Scholar
• Moliner-Urdiales D, Artero EG, Sui X, et al. Body adiposity index and incident hypertension: the aerobics center longitudinal study. Nutr Metab Cardiovasc Dis. 2014;24:969–975.
   PubMed Web of Science ®Google Scholar
• Du T, Sun X, Huo R, et al. Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes. 2014;38(2005):840–847.
   Web of Science ®Google Scholar
• Stepien M, Stepien A, Banach M, et al. New obesity indices and adipokines in normotensive patients and patients with hypertension: comparative pilot analysis. Angiology. 2014;65:333–342.
   PubMed Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007;116:39–48.
   PubMed Web of Science ®Google Scholar
• Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273–2282.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Katsuya T, Ishikawa K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension (Dallas, Tex : 1979). 2004;43:1318–1323.
   PubMed Web of Science ®Google Scholar
• Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001;19:523–528.
   PubMed Web of Science ®Google Scholar
• Dorresteijn JA, Visseren FL, Spiering W. Mechanisms linking obesity to hypertension. Obes Rev. 2012;13:17–26.
   PubMed Web of Science ®Google Scholar
• Bogaert YE, Linas S. The role of obesity in the pathogenesis of hypertension. Nat Clinical Practice Nephrol. 2009;5:101–111.
   PubMedGoogle Scholar